Lifecore Biomedical (LFCR) was upgraded by Barrington Research from "market perform" to "outperform". They now have a $5.50 price target on the stock.
Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Lifecore targets 12% revenue CAGR through 2029 as midterm pipeline milestones shift [Seeking Alpha]
Lifecore Biomedical Inc (LFCR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Lifecore Biomedical Q4 Earnings Call Highlights [Yahoo! Finance]